Aktienanalyse zu Oaktree Specialty Lending Corp (OCSL)OCSLOaktree Specialty Lending Corp

Oaktree Specialty Lending Corporation is a specialty finance company. The Company is engaged in providing customized one-stop credit solutions to companies with limited access to public or syndicated capital markets. The Company’s investment objective is to generate current income and capital appreciation by providing companies with financing solutions, including first and second lien loans, unsecured and mezzanine loans, and preferred equity. The Company may also seek to generate capital appreciation and income through secondary investments at discounts to par in either private or syndicated transactions. Its portfolio may also include certain structured finance and other non-traditional structures. Its portfolio of investments includes application software, multi-sector holdings, data processing and outsourced services, pharmaceuticals, biotechnology, health care services, specialized finance, and others. The Company is externally managed by Oaktree Fund Advisors, LLC (Oaktree). It operates in the Financials sector.

Oaktree Specialty Lending Corp is currently not a strong buy due to its low RSI of 27.209, indicating it is oversold, and a forward P/E of 8.9445, which suggests potential undervaluation. However, the recent revenue decline of 7.8% year-over-year and a significant drop in net income in Q2 2026 (-18889000.00 USD) raises concerns about future profitability. The stock's current price of $11.6 is below the analyst target of $13, but the overall market sentiment and performance trends suggest caution before making a purchase.

8 analysts cover OCSL: 3 rate it Buy, 5 Hold and 0 Sell. The average price target is 13.44.